Analyst Moves: JNJ, LNKD, INTC - Presented by: The Aol. On Network

This morning, Credit Suisse increased its price target on shares of Johnson & Johnson (JNJ) to $94 as growth from Invokana is expected to be better than originally expected. In the report, Credit Suisse maintained its underperform rating on the stock.



Related Videos

Most Popular Videos

Latest Videos


Most Active by Volume

Company Last Sale Change Net / %
BAC $ 16.40 0.20 ▼ 1.20%
AAPL $ 102.99 0.52 ▲ 0.51%
YHOO $ 42 1.82 ▲ 4.53%
NOK $ 7.93 0.24 ▼ 2.94%
FB $ 78.37 0.32 ▼ 0.41%
TVIX $ 3.81 0.49 ▲ 14.76%
BSX $ 12.32 0.29 ▲ 2.41%
PBR $ 12.83 0.37 ▼ 2.80%

As of 10/22/2014, 04:15 PM
More Most Active